NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ...

Adjusted EBITDA margins for 2025 are projected to be in the low 40% range, with operating expenses expected to grow by 18%-20%. EPS for 2025 is forecasted to fall between $5.50 and $5.90, with Q1 2025 ...

Canaccord Genuity Group Inc. reported a net loss of $11.6 million for its fiscal third quarter, despite record revenue ...

Neuronetics (STIM) announced that it has commenced an underwritten public offering of its common stock. Canaccord Genuity is acting as sole ...

Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, the Company expects to ...

Canaccord Genuity maintained their Buy rating and $80.00 price target on Roblox Corp . (NYSE:RBLX) stock, which currently trades at $65.31 with a market capitalization of $42.9 billion. Despite Roblox ...

Canaccord Genuity maintained a Buy rating with a $101.00 price target for Globus Medical (NYSE:GMED) shares, which currently trades at $88.54. The firm's analysis supports the company's ongoing ...

Currently trading with a volume of 8,605,127, the LUNR's price is up by 1.78%, now at $19.97. RSI readings suggest the stock ...

Strategy (NASDAQ:MSTR), formerly MicroStrategy, has drawn varied analyst reactions following its continued Bitcoin (CRYPTO: ...

Adjusted EPS guidance for FY2025 was updated to approximately $4.5, driven by lower interest costs and strong financial performance. The company anticipates Q4 2025 revenue of approximately $290 ...